US Patent 6,207,878
United States Patent and Trademark Office
University of Iowa Research Foundation (Iowa City, IA, US)
Disclosed is a transgenic knockout mouse whose genome has a homozygous disruption in its endogenous sarcospan gene, wherein the disruption prevents the synthesis of functional sarcospan in cells of the mouse. The mouse is characterized as exhibiting from 1.4 to 6.8 fold larger epididymal fat pad deposits as compared to the epididymal fat pad deposits of a wild type mouse. Methods for production of the mouse are presented. Also disclosed are cells derived from the transgenic knockout mouse. The mouse can be used in a method for identifying therapeutic agents for the treatment of an individual diagnosed with a metabolic disorder associated with a reduction or loss of expression of wild-type sarcospan. An example of such a disorder is weight gain in the individual associated with a reduction or loss of expression of wild-type sarcospan. These specific methods are also provided.
Campbell, Kevin P.; Lebakken, Connie; Crosbie, Rachelle; and Williamson, Roger Sarcospan-deficient mouse as a model for clinical disorders associated with sarcospan mutations. US Patent 6,207,878 filed October 21, 1999 and issued March 27, 2001. https://ir.uiowa.edu/patents/269